Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands

References

• Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71–96.
   PubMed Web of Science ®Google Scholar
• Aparicio T, Zaanan A, Svrcek M, Laurent-Puig P, Carrere N, Manfredi S, et al. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis 2014;46:97–104.
   PubMedGoogle Scholar
• Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg 2009;249:63–71.
   PubMed Web of Science ®Google Scholar
• Chow JS, Chen CC, Ahsan H, Neugut AI. A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990. Int J Epidemiol 1996;25:722–8.
   PubMed Web of Science ®Google Scholar
• Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients. Cancer 2004;101:518–26.
   PubMed Web of Science ®Google Scholar
• Chang HK, Yu E, Kim J, Bae YK, Jang KT, Jung ES, et al. Adenocarcinoma of the small intestine: a multi-institutional study of 197 surgically resected cases. Hum Pathol 2010;41:1087–96.
   PubMed Web of Science ®Google Scholar
• Howe JR, Karnell LH, Menck HR, Scott-Conner C, The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National cancer data base, 1985-1995. Cancer 1999;86:2693–706.
   PubMed Web of Science ®Google Scholar
• Neely D, Ong J, Patterson J, Kirkpatrick D, Skelly R. Small intestinal adenocarcinoma: rarely considered, often missed? Postgrad Med J 2013;89:197–201.
   PubMed Web of Science ®Google Scholar
• Shenoy S. Primary small-bowel malignancy: update in tumor biology, markers, and management strategies. J Gastrointest Cancer 2014;45:421–30.
   PubMedGoogle Scholar
• Lu Y, Frobom R, Lagergren J. Incidence patterns of small bowel cancer in a population-based study in Sweden: increase in duodenal adenocarcinoma. Cancer Epidemiol 2012;36:e158–63.
   PubMed Web of Science ®Google Scholar
• Negri E, Bosetti C, La Vecchia C, Fioretti F, Conti E, Franceschi S. Risk factors for adenocarcinoma of the small intestine. Int J Cancer 1999;82:171–4.
   PubMed Web of Science ®Google Scholar
• Mnatsakanyan E, Tung WC, Caine B, Smith-Gagen J. Cancer of unknown primary: time trends in incidence, United States. Cancer Causes Control 2014;25:747–57.
   PubMed Web of Science ®Google Scholar
• Anzidei M, Napoli A, Zini C, Kirchin MA, Catalano C, Passariello R. Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects. Br J Radiol 2011;84:677–90.
   PubMed Web of Science ®Google Scholar
• Lemmens VE, Bosscha K, van der Schelling G, Brenninkmeijer S, Coebergh JW, de Hingh IH. Improving outcome for patients with pancreatic cancer through centralization. Br J Surg 2011;98:1455–62.
   PubMed Web of Science ®Google Scholar
• Nienhuijs SW, van den Akker SA, de Vries E, de Hingh IH, Visser O, Lemmens VE. Nationwide improvement of only short-term survival after resection for pancreatic cancer in the Netherlands. Pancreas 2012;41:1063–6.
   PubMed Web of Science ®Google Scholar
• Kaw M, Singh S, Gagneja H. Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction. Surg Endosc 2003;17:457–61.
   PubMed Web of Science ®Google Scholar
• Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol 2010;49:474–9.
   PubMed Web of Science ®Google Scholar
• Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, et al. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis. Cancer 2016;122:693–701.
   PubMed Web of Science ®Google Scholar
• Fishman PN, Pond GR, Moore MJ, Oza A, Burkes RL, Siu LL, et al. Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases. Am J Clin Oncol 2006;29:225–31.
   PubMed Web of Science ®Google Scholar
• Khan K, Peckitt C, Sclafani F, Watkins D, Rao S, Starling N, et al. Prognostic factors and treatment outcomes in patients with small bowel adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) experience. BMC Cancer 2015;15:15.
   PubMed Web of Science ®Google Scholar
• Koo DH, Yun SC, Hong YS, Ryu MH, Lee JL, Chang HM, et al. Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study. BMC Cancer 2011;11:205.
   PubMed Web of Science ®Google Scholar
• Nicholl MB, Ahuja V, Conway WC, Vu VD, Sim MS, Singh G. Small bowel adenocarcinoma: understaged and undertreated? Ann Surg Oncol 2010;17:2728–32.
   PubMed Web of Science ®Google Scholar
• Scherubl H, Jensen RT, Cadiot G, Stolzel U, Kloppel G. Neuroendocrine tumors of the small bowels are on the rise: early aspects and management. World J Gastrointest Endosc 2010;2:325–34.
   PubMedGoogle Scholar
• Wu TJ, Yeh CN, Chao TC, Jan YY, Chen MF. Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis. World J Surg 2006;30:391–8.
   PubMed Web of Science ®Google Scholar